Cargando…
Withaferin A attenuates ovarian cancer-induced cardiac cachexia
Cachexia is a common multifactorial syndrome in the advanced stages of cancer and accounts for approximately 20–30% of all cancer-related fatalities. In addition to the progressive loss of skeletal muscle mass, cancer results in impairments in cardiac function. We recently demonstrated that WFA atte...
Autores principales: | Kelm, Natia Q., Straughn, Alex R., Kakar, Sham S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386592/ https://www.ncbi.nlm.nih.gov/pubmed/32722688 http://dx.doi.org/10.1371/journal.pone.0236680 |
Ejemplares similares
-
Withaferin A and Ovarian Cancer Antagonistically Regulate Skeletal Muscle Mass
por: Straughn, Alex R., et al.
Publicado: (2021) -
Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling
por: Straughn, Alex R., et al.
Publicado: (2019) -
Withaferin A: a potential therapeutic agent against COVID-19 infection
por: Straughn, Alex R., et al.
Publicado: (2020) -
Withaferin A Synergizes the Therapeutic Effect of Doxorubicin through ROS-Mediated Autophagy in Ovarian Cancer
por: Fong, Miranda Y., et al.
Publicado: (2012) -
Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells
por: Kakar, Sham S., et al.
Publicado: (2017)